Ultra- sustained-release multi-particulate dosage form of Doxycycline as a platform of repurposing therapeutics in the fight against COVID 19: in-vitro and in-silico study - Egyptian Knowledge Bank - troweb

216254

Ultra- sustained-release multi-particulate dosage form of Doxycycline as a platform of repurposing therapeutics in the fight against COVID 19: in-vitro and in-silico study

Article

Last updated: 22 Jan 2023

Overview Similar Items

Article

Doxycycline and Minocycline Drugs as a Treatment Proposal for Inhibition of ARDS and Inflammatory Cytokines of SARS-CoV-2

Article

Pharmacological studies on tetracycline and tetracycline nanoemulsion formulas

Article

Silica Nanoparticles as a Potential Carrier for Doxycycline Hyclate

Article

Pharmacokinetic properties of single doxycycline dose orally administered in the African catfish (Clarias gariepinus)

Article

ADVANCES AND DEVELOPMENTS IN DRUG REPURPOSING; STATE OF ART

Article

Recent Analytical Methodologies for Determination of Anti-Viral COVID-19 Drugs: A Review

Article

PREPARATION AND EVALUATION OF SUSTAINED RELEASE MATRIX FORMULATIONS OF VORICONAZOLE

Article

Repurposing Antiviral Drugs to Inhibit SARS-CoV-2 Papin-Like Protease Activity

Article

PREFORMULATION OF ANTITUBERCULOUS DRUGS IN POLYMERIC BASED FILMS

Article

FORMULATION DEVELOPMENT AND EVALUATION OF HIGHLY WATER-SOLUBLE DRUG-LOADED CONTROLLED RELEASE MATRIX TABLETS